Hemolytic-uremic syndrome surgery: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 23: Line 23:


== Indication ==
== Indication ==
* Surgical intervention is not recommended for the management of [disease name].
* Surgery is not the first-line treatment option for patients with HUS. Surgery is usually reserved for patients with gastrointestinal complications.
OR
* Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either:
** [Indication 1]
** [Indication 2]
** [Indication 3]
* The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either:
** [Indication 1]
** [Indication 2]
** [Indication 3]


==Surgery==
==Surgery==
Surgical intervention may be required in some patients who have gastrointestinal complications with severe colitis that progress to necrosis and in some cases lead to intestinal perforation.
* Surgical intervention may be required in some patients who have gastrointestinal complications with severe colitis that progress to necrosis and in some cases lead to intestinal perforation.
 
**
**



Revision as of 16:50, 17 August 2018

Hemolytic-uremic syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemolytic-uremic syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemolytic-uremic syndrome surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemolytic-uremic syndrome surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemolytic-uremic syndrome surgery

CDC on Hemolytic-uremic syndrome surgery

Hemolytic-uremic syndrome surgery in the news

Blogs on Hemolytic-uremic syndrome surgery

Directions to Hospitals Treating Hemolytic-uremic syndrome

Risk calculators and risk factors for Hemolytic-uremic syndrome surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Surgical intervention is not recommended for the management of [disease name].

OR

Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either [indication 1], [indication 2], and [indication 3]

OR

The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].

OR

The feasibility of surgery depends on the stage of [malignancy] at diagnosis.

OR

Surgery is the mainstay of treatment for [disease or malignancy].

Indication

  • Surgery is not the first-line treatment option for patients with HUS. Surgery is usually reserved for patients with gastrointestinal complications.

Surgery

  • Surgical intervention may be required in some patients who have gastrointestinal complications with severe colitis that progress to necrosis and in some cases lead to intestinal perforation.

References

Template:WH Template:WS